Balsam pear hypoglycemic MC-JJ0104 polypeptide analogue by microwave-accelerated solid-phase synthesis and application thereof

A MC-JJ0104, solid-phase synthesis technology, applied in the direction of medical preparations, peptides, drug combinations, etc. The effect of automatic production, low production cost and short synthesis cycle

Inactive Publication Date: 2010-09-15
CHINA PHARM UNIV
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Using the traditional solid-phase method to synthesize long peptides, the yield is often very low and the impurities are more difficult to purify, thus losing the meaning of synthesis from a practical point of view
Secondly, the synthesis cycle i

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0025] Microwave-promoted solid-phase synthesis of Gly-Pro-Ala-Ala-Tyr-Ile-Ser-Ala-Ala-Ser (SEQ.ID NO: 2)

[0026] (1) Swelling of the resin

[0027] Weigh 50mg of Fmoc-Ala Resin (substitution amount 0.4mmol / g), swell with 7mL DCM for 30min, filter to remove DCM, then swell with 10mL NMP for 30min, and finally rinse with NMP, DCM, and NMP 7mL respectively.

[0028] (2) Microwave promotes removal of Fmoc protecting group

[0029] Put the swollen resin into the reactor, add 7mL of 25% piperidine / NMP (V / V) solution containing 0.1M HOBT, react in the microwave reactor for 1min, the microwave power is 15W, and the reaction temperature is controlled at 50°C Within the time period, use an air compressor to compress the air to cool, and filter the solution after the reaction; add 7 mL of 25% piperidine / NMP (V / V) solution containing 0.1M HOBT and react in a microwave reactor for another 4 minutes, and the microwave power is 25W , the reaction temperature was controlled at 50°C, and c...

Embodiment 2

[0044] Gly-Pro-(D-Ala)-Ala-Tyr-Ile-Ser-Ala-Ala-Ser (SEQ.ID NO: 3); Theoretical relative molecular mass 907.0ESI-MSm / z: found[M+3H] 3+ 303.5, [M+4H] 4+ 227.6, [M+5H] 5+ 182.2;calu[M+3H] 3+ 303.3, [M+4H] 4+ 227.7, [M+5H] 5+ 182.4

Embodiment 3

[0046] Gly-Pro-Ala-(D-Ala)-Tyr-Ile-Ser-Ala-Ala-Ser (SEQ.ID NO: 4); Theoretical relative molecular mass 907.0ESI-MSm / z: found[M+3H] 3+ 303.3, [M+4H] 4+ 227.5, [M+5H] 5+ 182.4;calu[M+3H] 3+ 303.3, [M+4H] 4+ 227.7, [M+5H] 5+ 182.4

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a novel high-efficiency hypoglycemic balsam pear MC-JJ0104 polypeptide analogue and a microwave-accelerated solid-phase synthesis method. The MC-JJ0104 polypeptide analogue with longer pharmacological action time is obtained by modifying the 3, 4, 8 or 9 locus of a natural balsam pear polypeptide. The chemical synthesis of the polypeptide analogue is efficiently and quickly realized by the microwave-accelerated solid-phase synthesis method. The crude product is purified by a preparative scale high-efficiency liquid phase, and the MC-JJ0104 polypeptide analogue is finally obtained through freeze-drying.

Description

technical field [0001] The invention relates to a MC-JJ0104 polypeptide analog and a microwave-promoted solid-phase synthesis method thereof. Background technique [0002] Diabetes is an important disease that endangers human health today. At present, about 5%-7% of people in the world suffer from diabetes. It is considered to be the third largest killer of human disability and death after cardiovascular and cerebrovascular diseases and malignant tumors. . [0003] Diabetes is divided into type I and type II. Type I diabetes is an autoimmune disease that requires insulin injections for survival. Type II diabetes accounts for about 95% of the total number of diabetic patients. Type II diabetes is caused by metabolic disorders of islet cells, insufficient insulin secretion, or insulin resistance, which is a metabolic disease caused by insulin resistance mainly accompanied by relatively insufficient insulin secretion, or relatively insufficient insulin secretion accompanied b...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07K7/06C07K1/20C07K1/08C07K1/06C07K1/04A61K38/08A61P3/10
CPCY02P20/55
Inventor 黄文龙金晶钱海张惠斌王敬杰陈巍朱孝云华杰杜阔
Owner CHINA PHARM UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products